+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Global ENT Treatment Market Size was valued at USD 16.8 Billion in 2022. The ENT Treatment market industry is projected to grow from USD 17.9 Billion in 2023 to USD 29.4 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.70% during the forecast period (2023 - 2032). Ageing populations, an increase in the utilization of minimally invasive ENT procedures, and the prevalence of ENT-related ailments, are the key market drivers enhancing the market growth.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
Some of the key trends propelling market expansion include aging populations, an increase in ENT-related disorders, and a rise in the adoption of minimally invasive ENT procedures. Technology advancements are crucial to the market's growth. The demand for contemporary ENT devices and systems, such as robot-assisted endoscopes, is low in emerging economies due to their expensive cost and the fact that their use is mostly restricted to wealthy countries like the U.S. It is anticipated that increased healthcare spending by other nations and rising per capita income will significantly expand market penetration. Sales are anticipated to increase significantly in developing countries due to the high prevalence of ENT conditions like hearing loss and sinusitis as well as greater efforts to improve access to healthcare facilities in these countries.
Hearing loss or impairment is one of the most common medical conditions, especially in industrialized nations. According to the WHO, approximately 460 million people, or nearly 5% of the world's population, currently experience an incapacitating hearing loss. One in ten people, or over 900 million, are anticipated to live in that area by 2050. Two of the main causes of this are a rise in life expectancy and an increase in noise pollution, which both contribute to an increase in cases of hearing loss brought on by aging. Middle ear infections, meningitis, and measles are all common causes of hearing loss in low-income countries. Additionally, chronic inflammation, noise exposure, vascular problems, physiologic aging of the ear, and hereditary susceptibility can all contribute to hearing loss.
The sector is expanding thanks to the application of cutting-edge technologies like AI and ML as well as improvements in audio goods. For instance, the health technology company Audibel unveiled the AI hearing aid Arc-AI in October 2021. It is configured to automatically modify hearing volume and comes in a range of styles, including behind-the-ear and entirely in-canal. In January 2019, Lively unveiled an online audiology platform that provides all customers with hearing aids, testing, and round-the-clock online support. All platform users have the ability to establish a video conference connection with an audiologist and purchase hearing aids without needing to visit a clinic or retail location.
The increased use of various supportive devices in the healthcare sectors is directly impacted by growing awareness of device availability in the global ENT treatment market. Governments from all around the world have been seen encouraging crucial education to promote awareness of many accessible and efficient medical technology, such as ENT diagnostics and hearing aids. In the upcoming years, there will be an increase in consumer demand for nose surgery and government support in the form of finance, grants, and subsidies, which will lead to growth in the global market for ENT therapies. Thus, driving the ENT Treatment market revenue.
The global ENT Treatment market segmentation, based on Drug Type, includes antibiotics, antihistamines, steroids, anti-inflammatory drugs, and others. Antibiotics segment dominated the global market in 2022. The dominance of this market segment may be attributed to an increase in ENT diseases, which are becoming more widespread as a result of increased air and noise pollution as well as bacterial concentrations in the environment, which cause a variety of infections such sinusitis and chronic rhinitis infection. As a result, the need for antibiotics to treat ENT problems is increased.
The global ENT Treatment market segmentation, based on Organ Type, includes ear, nose, and throat. Nose segment dominated the global ENT Treatment market in 2022. This is brought on by an increase in the prevalence of allergic rhinitis and viral infections, two conditions that are propelling the market's growth. The throat segment is expected to experience rapid growth in the market for treating ENT problems. The increase in viral infections, which can lead to upper respiratory infections, sore throats, and irritation, is the primary driver fueling the market's expansion.
The global ENT Treatment market segmentation, based on Devices, includes hearing aid devices, voice prosthesis, nasal splints, hearing implants, endoscopes, and others. Hearing aid devices segment dominated the global market in 2022. This is as a result of more new firms joining the market, increased usage of these devices, and the advancement of technology as a result of increased R&D spending by market participants. On the other hand, it is projected that the category for endoscopes would expand at the fastest rate in the upcoming years. This is due to the creation of numerous practical surgical endoscopes as a result of endoscopic research and development.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
The global ENT Treatment market segmentation, based on End User, includes hospitals, clinics, ambulatory surgical centers, home care settings, and others. Hospitals segment dominated the global ENT Treatment market in 2022. The primary growth drivers for this market are increased disposable income, better healthcare infrastructure and spending, rising ENT treatment affordability, and growing knowledge and awareness of the procedure's success or failure.
By region, Insights into the markets in North America, Europe, Asia-Pacific, and the rest of the world are provided by the study. The Asia Pacific ENT Treatment market dominated this market in 2022 (45.80%). Rising healthcare spending, rising investment from market participants, and rising healthcare expenses are the causes of this. Olympus Corporation, based in Japan, announced the ENF-VT3 in May 2018 to provide a rhino-laryngo videoscope with 4-direction angulation capability in Europe. Moreover, In the Asia-Pacific region, the Indian ENT Treatment market had the quickest rate of growth while China's ENT Treatment market had the greatest market share.
Further, the major countries studied in the market report are The U.S., Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
The North America ENT Treatment Market is expected to register significant growth from 2023 to 2032. This is brought on by a variety of elements, including the high prevalence of ENT-related illnesses in the area, the expanding need for hearing care products, the presence of significant hospital chains, well-equipped ambulatory facilities, and a huge target market. Major market players' local presence, favourable government laws for portable medical devices, and broad adoption of cutting-edge technology are further market drivers. Further, In the North American area, the U.S. ENT Treatment market had the biggest market share, while the Canada ENT Treatment market had the quickest rate of expansion.
Europe ENT Treatment market accounted for the healthy market share in 2022. Hearing aid product adoption is high in the area as a result of the well-established healthcare infrastructure and high patient awareness levels. Further, In the European region, the German ENT Treatment market had the biggest market share, and the U.K. ENT Treatment market had the quickest rate of growth.
Leading industry companies are making significant R&D investments in order to diversify their product offerings, which will drive the ENT Treatment market's expansion. Important market developments include new product releases, contractual agreements, mergers and acquisitions, greater investments, and collaboration with other organizations. Market participants are also engaging in a number of strategic actions to increase their global footprint. The ENT Treatment sector needs to provide affordable products if it wants to grow and thrive in a more competitive and challenging market environment.
One of the primary business strategies employed by manufacturers in the worldwide Aerospace Foam industry to assist customers and expand the market sector is local manufacturing to reduce operational costs. Some of the biggest benefits to medicine have recently come from the ENT Treatment sector. Major players in the ENT Treatment market, including Novartis AG, Pfizer Inc., GlaxoSmithKline Pharmaceuticals, Teva Pharmaceuticals Industries Ltd., Sonova Holding AG, Starkey Laboratories Inc., Siemens Healthcare, Sonic Innovations Inc., American Hearing Systems Inc., and Dr. Reddy’s Laboratories Ltd., are attempting to increase market demand by investing in research and development Devicess.
The company Oticon creates hearing aids with the intention of enhancing people's quality of life through improved hearing. The company's product uses technology that makes it possible for phone calls, televisions, and music to be connected directly to hearing aids. This technology benefits people with all types of hearing loss, regardless of age or lifestyle, by giving them access to all speech and pertinent sounds and, in the process, separating speech from noise. With the aid of this technology, hearing healthcare professionals may offer patients the finest support at a time that is convenient for everyone involved, and patients can benefit from enhanced speech clarity and less listening strain. In February 2022, Oticon expanded the selection of hearing aids it sells in an effort to assist even more people with hearing loss in taking use of the company's cutting-edge BrainHearing technology.
A company that specializes in medical technology under the name of Medtronic Plc (Medtronic), formerly known as Medtronic Inc., designs, develops, manufactures, and sells a wide range of medical items. It offers treatments for ailments such heart valve problems, heart failure, aortic, peripheral vascular, venous renal, and neurological problems, as well as for illnesses affecting the spine and musculoskeletal system and the ears, nose, and throat. It also provides biologic solutions for the orthopedic and dental markets. It sells its goods to hospitals, clinics, institutions, government health care programs, distributors, and group buying organizations throughout Asia Pacific, Europe, the Americas, the Middle East, and Africa. Dublin, Ireland is home to Medtronic's corporate headquarters. In February 2022, Medtronic unveiled the NuVent Eustachian tube dilation balloon, giving surgeons an outpatient option for various ear, nose, and throat conditions.
· Novartis AG
· Pfizer Inc.
· GlaxoSmithKline Pharmaceuticals
· Teva Pharmaceuticals Industries Ltd.
· Sonova Holding AG
· Starkey Laboratories Inc.
· Siemens Healthcare
· Sonic Innovations Inc.
· American Hearing Systems Inc.
· Dr. Reddy’s Laboratories Ltd.v
January 2022: The industry's first artificial intelligence (AI)-powered ENT device was launched by Acclarent Inc., a division of Johnson & Johnson Medical Devices Companies, with the goal of streamlining surgical planning and providing real-time feedback throughout ENT navigation procedures.
· Hearing Aid Devices
· Voice Prosthesis
· Nasal Splints
· Hearing Implants
· Endoscopes
· Others
· Antibiotics
· Antihistamines
· Steroids
· Anti-inflammatory Drugs
· Others
· Ear
· Nose
· Throat
· Hospitals
· Clinics
· Ambulatory Surgical Centers
· Home Care Settings
· Others
· North America
- U.S.
- Canada
· Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
· Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
· Rest of the World
- Middle East
- Africa
- Latin America
Report Scope
|
Report Attribute/Metric |
Details |
|
Market Size 2022 |
USD 16.8 Billion |
|
Market Size 2023 |
USD 17.9 Billion |
|
Market Size 2032 |
USD 29.4 Billion |
|
Compound Annual Growth Rate (CAGR) |
6.70% (2023-2032) |
|
Base Year |
2022 |
|
Market Forecast Period |
2023-2032 |
|
Historical Data |
2018- 2022 |
|
Market Forecast Units |
Value (USD Billion) |
|
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
Devices, Drug Type, Organ Type, End User, and Region |
|
Geographies Covered |
North America, Europe, Asia Pacific, and the Rest of the World |
|
Countries Covered |
The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
|
Key Companies Profiled |
Novartis AG, Pfizer Inc., GlaxoSmithKline Pharmaceuticals, Teva Pharmaceuticals Industries Ltd., Sonova Holding AG, Starkey Laboratories Inc., Siemens Healthcare, Sonic Innovations Inc., American Hearing Systems Inc., and Dr. Reddy’s Laboratories Ltd. |
|
Key Market Opportunities |
Surge in demand for cosmetic ear nose throat (ENT) operations |
|
Key Market Dynamics |
Increasing penetration of minimally invasive ENT procedures, increasing prevalence of ENT-related disorders, and rising geriatric population |
The global ENT Treatment Market was valued at USD 16.8 billion in 2022, and it is estimated to reach USD 29.4 billion by 2032.
The global market is projected to grow at a CAGR of 6.70% during the forecast period, 2023-2032
North America had the largest share in the global market
The key players in the market are Novartis AG, Pfizer Inc., GlaxoSmithKline Pharmaceuticals, Teva Pharmaceuticals Industries Ltd., Sonova Holding AG, Starkey Laboratories Inc., Siemens Healthcare, Sonic Innovations Inc., American Hearing Systems Inc., and Dr. Reddy’s Laboratories Ltd.
The Hearing Aid Devices, Devices dominated the market in 2022.
The Antibiotics Drug Type had the largest share in the global market.
Report Code :
RL6575
Published on :
Aug 2023
Request a Free Sample Report
Speak to Analyst